Svetlana A. Loskutova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Svetlana A. Loskutova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Tamara V. Belousova
Novosibirsk State Medical University
5 shared publications - Anastasia O. Zatolokina
Novosibirsk State Medical University
4 shared publications - Valeriy A. Plyushkin
Novosibirsk State Medical University
2 shared publications Плюшкин Валерий Александрович
ФГБОУ ВО «Новосибирский государственный медицинский университет» Минздрава России
2 shared publicationsAnastasia M. Dagaeva
Novosibirsk State Medical University
1 shared publication- Anna B. Nikulina
Novosibirsk State Medical University
1 shared publication
Latest Publications
- Open Access
- 20 November 2024
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 21 (5) , 432-439
The Importance of the Skin Syndrome in the Primary Diagnosis of Connective Tissue Diseases in Children: Case Report
Background. Timely verification of the clinical diagnosis of connective tissue diseases in children based on the onset of the earliest symptoms, including skin manifestations, and timely initiation of treatment can prevent the development of irreversible complications, increase the life expectancy of patients and its quality.The aim of the study. To analyze the nature of skin manifestations as a marker of the onset connective tissue disorders, such as systemic lupus erythematosus (SLE), localized scleroderma (morphea), juvenile dermatomyositis (JDM), juvenile polyarteritis nodosa (PAN), systemic juvenile idiopathic arthritis (SJIA), and the timing of the main clinical diagnosis from the moment of manifestation of connective tissue disorders. To clearly demonstrate the importance of skin syndrome in the timeliness of clinical diagnosis, a clinical case is presented.Methods. Analysis of medical records and prospective observation of 47 patients aged up to 17 years 11 months with an established diagnosis of connective tissue diseases and the presence of skin syndrome at the onset of the disease.Results. Among patients with SLE, only 20.0% of children had skin syndrome only in the form of butterfly rash, and other skin manifestations were noted in 80.0% of patients. The period from the onset of skin syndrome to diagnosis was 8.0 ± 2.1 months. In 57.2% of patients with morphea, skin syndrome was detected exclusively in the form of single or multiple elements, and in 42.8% there was a combination of a pathognomonic morphological element with alopecia and scleroderma. The average time to make a clinical diagnosis of morphea from the onset of the skin syndrome was 11.0 ± 1.9 months. In all patients with JDM, skin manifestations were characterized by polymorphism (papules and Gottron’s sign, heliotrope rash, palmar capillaritis, livedo reticularis, cheilitis). The diagnosis was made 14.0 ± 3.2 months from the onset of skin syndrome. In patients with documented PAN, skin manifestations debuted in the form of erythema, areas of necrosis, palmar capillaritis, livedo reticularis, and cheilitis. The period from the onset of skin syndrome to clinical diagnosis was 6.0 ± 2.4 months. Among patients with SJIA, skin syndrome was represented by a maculopapular rash associated with fever and its regression when body temperature normalized. The period until clinical diagnosis was made from the onset of the skin syndrome was 2.0 ± 1.1 months.Conclusion. In most cases, the skin syndrome in patients at the onset of the disease was characterized by polymorphism and diversity of elements with the involvement of the vascular component. At the same time, the time from the debut of connective tissue disease in the form of the appearance of skin syndrome to the clinical diagnosis varied in the range from 2 to 14 months.
- 20 November 2024
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 21 (5) , 432-439
Open AccessThe Importance of the Skin Syndrome in the Primary Diagnosis of Connective Tissue Diseases in Children: Case Report
Background. Timely verification of the clinical diagnosis of connective tissue diseases in children based on the onset of the earliest symptoms, including skin manifestations, and timely initiation of treatment can prevent the development of irreversible complications, increase the life expectancy of patients and its quality.The aim of the study. To analyze the nature of skin manifestations as a marker of the onset connective tissue disorders, such as systemic lupus erythematosus (SLE), localized scleroderma (morphea), juvenile dermatomyositis (JDM), juvenile polyarteritis nodosa (PAN), systemic juvenile idiopathic arthritis (SJIA), and the timing of the main clinical diagnosis from the moment of manifestation of connective tissue disorders. To clearly demonstrate the importance of skin syndrome in the timeliness of clinical diagnosis, a clinical case is presented.Methods. Analysis of medical records and prospective observation of 47 patients aged up to 17 years 11 months with an established diagnosis of connective tissue diseases and the presence of skin syndrome at the onset of the disease.Results. Among patients with SLE, only 20.0% of children had skin syndrome only in the form of butterfly rash, and other skin manifestations were noted in 80.0% of patients. The period from the onset of skin syndrome to diagnosis was 8.0 ± 2.1 months. In 57.2% of patients with morphea, skin syndrome was detected exclusively in the form of single or multiple elements, and in 42.8% there was a combination of a pathognomonic morphological element with alopecia and scleroderma. The average time to make a clinical diagnosis of morphea from the onset of the skin syndrome was 11.0 ± 1.9 months. In all patients with JDM, skin manifestations were characterized by polymorphism (papules and Gottron’s sign, heliotrope rash, palmar capillaritis, livedo reticularis, cheilitis). The diagnosis was made 14.0 ± 3.2 months from the onset of skin syndrome. In patients with documented PAN, skin manifestations debuted in the form of erythema, areas of necrosis, palmar capillaritis, livedo reticularis, and cheilitis. The period from the onset of skin syndrome to clinical diagnosis was 6.0 ± 2.4 months. Among patients with SJIA, skin syndrome was represented by a maculopapular rash associated with fever and its regression when body temperature normalized. The period until clinical diagnosis was made from the onset of the skin syndrome was 2.0 ± 1.1 months.Conclusion. In most cases, the skin syndrome in patients at the onset of the disease was characterized by polymorphism and diversity of elements with the involvement of the vascular component. At the same time, the time from the debut of connective tissue disease in the form of the appearance of skin syndrome to the clinical diagnosis varied in the range from 2 to 14 months.
- Open Access
- 8 June 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 88-93
Characteristics of chronic non-bacterial osteomyelitis in children living in the Novosibirsk region
Background. Chronic non-bacterial osteomyelitis (CNO) is a rare autoinflammatory bone disease that has been insufficiently studied and described in the scientific medical literature. Due to the lack of specific laboratory and instrumental criteria, a complex interdisciplinary differential diagnosis is required. Aim. To study the clinical manifestations of the onset of the disease, the features of the course, and the results of laboratory and instrumental diagnostic methods in pediatric patients living in the Novosibirsk region diagnosed with CNO. Materials and methods. A retro- and prospective observational study was conducted, and inpatient records were analyzed in patients under 18 with a documented diagnosis of CNO, SAPHO syndrome, and hospitalized in the State Novosibirsk Regional Clinical Hospital departments. Results. In the Novosibirsk region, relatively early detection of CNO is carried out, with an average diagnostic gap of about six months. Less than half (34%) of the patients from the observation group were referred to a pediatric rheumatologist at the initial visit for bone pain despite the presence of concomitant articular syndrome in most of them (70%). The most common affected area in CNO is the spine (30%), followed by the femur (19%) and pelvis (16%). Notably, at the onset of the disease, monofocal bone tissue lesions were common (52%). Pain and loss of function in the bone lesion area were typical complaints in all patients with CNO. Articular syndrome was also common. Conclusion. CNO, being a rare autoinflammatory disease, requires a relatively complex multidiscipline differential diagnosis; its outcomes largely depend on the timing of the diagnosis.
- 8 June 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 88-93
Open AccessCharacteristics of chronic non-bacterial osteomyelitis in children living in the Novosibirsk region
Background. Chronic non-bacterial osteomyelitis (CNO) is a rare autoinflammatory bone disease that has been insufficiently studied and described in the scientific medical literature. Due to the lack of specific laboratory and instrumental criteria, a complex interdisciplinary differential diagnosis is required. Aim. To study the clinical manifestations of the onset of the disease, the features of the course, and the results of laboratory and instrumental diagnostic methods in pediatric patients living in the Novosibirsk region diagnosed with CNO. Materials and methods. A retro- and prospective observational study was conducted, and inpatient records were analyzed in patients under 18 with a documented diagnosis of CNO, SAPHO syndrome, and hospitalized in the State Novosibirsk Regional Clinical Hospital departments. Results. In the Novosibirsk region, relatively early detection of CNO is carried out, with an average diagnostic gap of about six months. Less than half (34%) of the patients from the observation group were referred to a pediatric rheumatologist at the initial visit for bone pain despite the presence of concomitant articular syndrome in most of them (70%). The most common affected area in CNO is the spine (30%), followed by the femur (19%) and pelvis (16%). Notably, at the onset of the disease, monofocal bone tissue lesions were common (52%). Pain and loss of function in the bone lesion area were typical complaints in all patients with CNO. Articular syndrome was also common. Conclusion. CNO, being a rare autoinflammatory disease, requires a relatively complex multidiscipline differential diagnosis; its outcomes largely depend on the timing of the diagnosis.
- 15 December 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (6)
Autoinflammatory diseases in the pediatric neonatologist’s and physician’s practices: series of clinical cases
- 15 December 2023
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 102 (6)
Autoinflammatory diseases in the pediatric neonatologist’s and physician’s practices: series of clinical cases
- Open Access
- 6 June 2023
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 81-85
Progressive familial intrahepatic cholestasis type 2 on the example of one family. Liver transplantation as an effective treatment method. Case report
The article presents the structure of diseases that led to the need for liver sector transplantation in children living in the Novosibirsk region. The paper provides a detailed description of progressive familial intrahepatic cholestasis, principles of modern diagnosis and treatment. A description of the medical history of family members and, in particular, a clinical case in a young child with type 2 PFIC (Byler's syndrome) is given.
- 6 June 2023
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 81-85
Open AccessProgressive familial intrahepatic cholestasis type 2 on the example of one family. Liver transplantation as an effective treatment method. Case report
The article presents the structure of diseases that led to the need for liver sector transplantation in children living in the Novosibirsk region. The paper provides a detailed description of progressive familial intrahepatic cholestasis, principles of modern diagnosis and treatment. A description of the medical history of family members and, in particular, a clinical case in a young child with type 2 PFIC (Byler's syndrome) is given.
- Open Access
- 26 September 2022
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 3,p. 239-243
Case report of pulmonary embolism in pediatric practice
An analysis of the clinical situation of a 14-year-old patient with pulmonary embolism (PE) and current information on the risk factors for the development of thrombotic events are presented. Due to the presence of gynecological pathology, the girl was prescribed hormonal drugs, in particular, dydrogesterone and estrogen + gestagen. Against the background of its use, complaints of shortness of breath appeared, which was regarded as a manifestation of bronchial obstruction and bronchodilator therapy was prescribed. Due to the lack of positive dynamics during treatment, she was hospitalized. MSCT of the chest organs was performed: signs of PE were revealed; A molecular genetic study of the DNA of buccal epithelial cells (PCR) was carried out: the carriage of prothrombogenic polymorphic variants of genes of the hemostasis system was revealed, the most significant of which is a heterozygous mutation of the prothrombin FII gene (G20210A); the study of the hemostasis system revealed thrombinemia. In therapy, thrombolysis was not performed, low molecular weight heparins were prescribed the child's condition improved. The question of the need for a comprehensive examination, including research on the carriage of prothrombogenic polymorphic variants of the genes of the hemostasis system for pediatric patients in situations requiring the administration of hormonal drugs for a long course, to prevent the ocurrence of dangerous thrombotic complications, is discussed.
- 26 September 2022
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 3,p. 239-243
Open AccessCase report of pulmonary embolism in pediatric practice
An analysis of the clinical situation of a 14-year-old patient with pulmonary embolism (PE) and current information on the risk factors for the development of thrombotic events are presented. Due to the presence of gynecological pathology, the girl was prescribed hormonal drugs, in particular, dydrogesterone and estrogen + gestagen. Against the background of its use, complaints of shortness of breath appeared, which was regarded as a manifestation of bronchial obstruction and bronchodilator therapy was prescribed. Due to the lack of positive dynamics during treatment, she was hospitalized. MSCT of the chest organs was performed: signs of PE were revealed; A molecular genetic study of the DNA of buccal epithelial cells (PCR) was carried out: the carriage of prothrombogenic polymorphic variants of genes of the hemostasis system was revealed, the most significant of which is a heterozygous mutation of the prothrombin FII gene (G20210A); the study of the hemostasis system revealed thrombinemia. In therapy, thrombolysis was not performed, low molecular weight heparins were prescribed the child's condition improved. The question of the need for a comprehensive examination, including research on the carriage of prothrombogenic polymorphic variants of the genes of the hemostasis system for pediatric patients in situations requiring the administration of hormonal drugs for a long course, to prevent the ocurrence of dangerous thrombotic complications, is discussed.